Highlights section Myocarditis in the course of SARS-CoV-2 infection is highly over-diagnosed. The term „myocarditis” should be used only for endomyocardial biopsy- and/or autopsy- proven diagnosis. There is still no proof that SARS-CoV-2 can cause direct cardiomyocyte damage.

ClinicalTrials.gov, NCT03104231. Registered on 28 March 2017.

Background: Endothelial dysfunction (ED) frequently precedes cardiovascular diseases (CVD) and is a well-established ; p = 0.008) and higher than in the ivabradine group (1.6 ± 3.61 vs -0.3 ± 1.66; p = 0.02 (Cardiol J 2015; 22, 6: 708-716)

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited, distributed under the same license, and used for noncommercial purposes only.

No abstract